Status:
RECRUITING
Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation
Lead Sponsor:
Baystate Medical Center
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The increasing morbidity and mortality of the opioid epidemic has necessitated a reevaluation of current addiction treatment paradigms: medications for opioid use disorder, such as buprenorphine and m...
Detailed Description
Participants (ED patients with untreated opioid use disorder) will be enrolled and followed prospectively before and after an ED-wide intervention training clinicians to use "Talk About It," a paper-b...
Eligibility Criteria
Inclusion
- Patients aged 16 and older
- presenting with indications for Medications for Opioid Use Disorder (MOUD) initiation (opioid overdose, opioid withdrawal, complications of injection opioid use, untreated OUD)
- not currently on buprenorphine or methadone (in the past 7 days).
- (Buprenorphine is FDA approved for patients aged 16 and older, so 16- and 17-year-olds may be included with parental consent.)
Exclusion
- No Opioid Use Disorder (OUD)
- already on MOUD
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2026
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06527820
Start Date
June 1 2024
End Date
August 30 2026
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baystate Medical Center
Springfield, Massachusetts, United States, 01199